Kolexia
Delchier Jean Charles Gastro-entérologie
Delchier Jean Charles
Gastro-entérologie
Hôpital Henri Mondor
Créteil, France
56 Activités
78 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infections à Helicobacter Lymphomes Tumeurs de l'estomac Lymphome B de la zone marginale Maladie de Crohn Rectocolite hémorragique Maladies inflammatoires intestinales Lymphome malin non hodgkinien Colite

Collaborateurs

Voir plus
Amiot Aurelien
Amiot Aurelien
Hôpital Henri Mondor, Créteil, France
Le Baleur Yann
Le Baleur Yann
Hôpital Marie Lannelongue, Le Plessis-Robinson, France
Sobhani Iradj
Sobhani Iradj
Hôpital Henri Mondor, Créteil, France
Levy Michael
Levy Michael
Hôpital Henri Mondor, Créteil, France

Industries

Voir plus
Ferring
1 collaboration(s)
Dernière en 2016
Takeda Pharmaceutical
1 collaboration(s)
Dernière en 2016
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Efficacy of a tailored PCR-guided triple therapy in the treatment of Helicobacter pylori infection.
Medecine et maladies infectieuses   27 juin 2019
Helicobacter pylori, gastric cancer and other gastrointestinal malignancies.
Helicobacter   08 mai 2018
Long-term course of precancerous lesions arising in patients with gastric MALT lymphoma.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   27 octobre 2017
Helicobacter pylori, gastric cancer and other gastrointestinal malignancies
XXXth International Workshop on Helicobacter \u0026amp; Microbiota in Inflammation \u0026amp; Cancer, 7–9 September 2017, Bordeaux, France   10 septembre 2017
Hepysé: Comparison of the Efficacy and Tolerance of Triple Therapy Guided by the PCR Detection of Clarithromycin Resistance WITH Empiric Concomitant Quadruple Therapy for Helicobacter Pylori Infection: a Randomised Multicentre Trial
Essai Clinique (Assistance publique – Hôpitaux de Paris)   03 juillet 2017
Efficacy and Safety of Quadruple Therapy in Eradication of H. Pylori: A Comparison to Triple Therapy: Efficacy and Safety of Quadruple Therapy by Bismuth Subcitrate Potassium, Metronidazole, and Tetracycline Given X 10 Days With Omeprazole in Eradication of Helicobacter Pylori: A Comparison to Omeprazole, Amoxicillin and Clarithromycin Given X 7 Days
Essai Clinique (Forest Laboratories)   08 février 2017
Second primary malignancies in patients treated for gastric mucosa-associated lymphoid tissue lymphoma.
Leukemia & lymphoma   31 janvier 2017
Rescue therapy with bismuth-containing quadruple therapy in patients infected with metronidazole-resistant Helicobacter pylori strains.
Clinics and research in hepatology and gastroenterology   02 février 2016
Therapeutic drug monitoring is predictive of loss of response after de-escalation of infliximab therapy in patients with inflammatory bowel disease in clinical remission.
Clinics and research in hepatology and gastroenterology   29 juin 2015
Letter: Bismuth quadruple therapy with Pylera for Helicobacter pylori infection--authors' reply.
Alimentary pharmacology & therapeutics   20 octobre 2014